1,265
Views
16
CrossRef citations to date
0
Altmetric
Review

Management of insomnia in alcohol use disorder

ORCID Icon, &
Pages 297-306 | Received 03 Oct 2019, Accepted 12 Dec 2019, Published online: 03 Jan 2020

References

  • Brower KJ, Aldrich MS, Robinson EA, et al. Insomnia, self-medication, and relapse to alcoholism. Am J Psychiatry. 2001;158:399–404.
  • Zhabenko N, Wojnar M, Brower KJ. Prevalence and correlates of insomnia in a polish sample of alcohol-dependent patients. Alcohol Clin Exp Res. 2012;36:1600–1607.
  • Kolla BP, Schneekloth T, Biernacka J, et al. The course of sleep disturbances in early alcohol recovery: an observational cohort study. Am J Addict. 2014;23:21–26.
  • Brower KJ, Krentzman A, Robinson EAR. Persistent insomnia, abstinence, and moderate drinking in alcohol-dependent individuals. Am J Addict. 2011;20:435–440.
  • Conroy DA, Arnedt JT, Brower KJ, et al. Perception of sleep in recovering alcohol-dependent patients with insomnia: relationship with future drinking. Alcohol Clin Exp Res. 2006;30:1992–1999.
  • Foster JH, Peters TJ. Impaired sleep in alcohol misusers and dependent alcoholics and the impact upon outcome. Alcohol Clin Exp Res. 1999;23:1044–1051.
  • Dolsen MR, Harvey AG. Life-time history of insomnia and hypersomnia symptoms as correlates of alcohol, cocaine and heroin use and relapse among adults seeking substance use treatment in the United States from 1991 to 1994. Addiction. 2017;112:1104–1111.
  • Chakravorty S, Grandner MA, Mavandadi S, et al. Suicidal ideation in veterans misusing alcohol: relationships with insomnia symptoms and sleep duration. Addict Behav. 2014;39:399–405.
  • Baglioni C, Battagliese G, Feige B, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135:10–19.
  • Zhabenko O, Krentzman AR, Robinson EAR, et al. A longitudinal study of drinking and depression as predictors of insomnia in alcohol-dependent individuals. Subst Use Misuse. 2013;48:495–505.
  • Kessler RC, Berglund PA, Coulouvrat C, et al. Insomnia and the performance of US workers: results from the America insomnia survey. Sleep. 2011;34:1161–1171.
  • Kessler RC, Berglund PA, Coulouvrat C, et al. Insomnia, comorbidity, and risk of injury among insured Americans: results from the America insomnia survey. Sleep. 2012;35:825–834.
  • Dragioti E, Bernfort L, Larsson B, et al. Association of insomnia severity with well-being, quality of life and health care costs: a cross-sectional study in older adults with chronic pain (PainS65+). Eur J Pain. 2018;22:414–425.
  • Morin CM, Drake CL, Harvey AG, et al. Insomnia disorder. Nat Rev Dis Primers. 2015;1:15026.
  • Morin CM, Benca R. Chronic insomnia. Lancet. 2012;379:1129–1141.
  • Brower KJ. Assessment and treatment of insomnia in adult patients with alcohol use disorders. Alcohol. 2015;49:417–427.
  • Miller MB, Donahue ML, Carey KB, et al. Insomnia treatment in the context of alcohol use disorder: a systematic review and meta-analysis. Drug Alcohol Depend. 2017;181:200–207.
  • Friedmann PD, Herman DS, Freedman S, et al. Treatment of sleep disturbance in alcohol recovery: a national survey of addiction medicine physicians. J Addict Dis. 2003;22:91–103.
  • Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26:675–700.
  • Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American college of physicians. Ann Int Med. 2016;165:125–133.
  • Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4:487–504.
  • Chakravorty S, Chaudhary NS, Brower KJ, et al. Its relationship with insomnia and other sleep disorders. Alcohol Clin Exp Res. 2016;40:2271–2282.
  • Kolla BP, Mansukhani MP, Schneekloth T. Pharmacological treatment of insomnia in alcohol recovery: a systematic review. Alcohol Alcohol. 2011;46:578–585.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author; 2013.
  • ICSD-3 Online Version - American Academy of Sleep Medicine (AASM) [Internet]. AASM. [cited 2016 Feb 25]. Available from: http://www.aasmnet.org/store/product.aspx?pid=849
  • He S, Brooks AT, Kampman KM, et al. The relationship between alcohol craving and insomnia symptoms in alcohol-dependent individuals. Alcohol Alcohol. 2019;54:287–294.
  • Currie SR, Clark S, Hodgins DC, et al. Randomized controlled trial of brief cognitive-behavioural interventions for insomnia in recovering alcoholics. Addiction. 2004;99:1121–1132.
  • Arnedt JT, Conroy D, Rutt J, et al. An open trial of cognitive-behavioral treatment for insomnia comorbid with alcohol dependence. Sleep Med. 2007;8:176–180.
  • Arnedt JT, Conroy DA, Armitage R, et al. Cognitive-behavioral therapy for insomnia in alcohol dependent patients: a randomized controlled pilot trial. Behav Res Ther. 2011;49:227–233.
  • Chakravorty S, Morales KH, Arnedt JT, et al. Cognitive behavioral therapy for insomnia in alcohol-dependent veterans: a randomized, controlled pilot study. Alcohol Clin Exp Res. 2019;43:1244–1253.
  • Brooks AT, Tuason RT, Chakravorty S, et al. Online cognitive behavioral therapy for insomnia (CBT-I) for the treatment of insomnia among individuals with alcohol use disorder: study protocol for a randomized controlled trial. Pilot Feasibility Stud. 2018;4:183.
  • Greeff AP, Conradie WS. Use of progressive relaxation training for chronic alcoholics with insomnia. Psychol Rep. 1998;82:407–412.
  • Mueller TI, Pagano ME, Rodriguez BF, et al. Long-term use of benzodiazepines in participants with comorbid anxiety and alcohol use disorders. Alcohol Clin Exp Res. 2005;29:1411–1418.
  • Walsh JK, Krystal AD, Amato DA, et al. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep. 2007;30:959–968.
  • Roehrs T, Roth T. Insomnia pharmacotherapy. Neurotherapeutics. 2012;9:728–738.
  • Ashton H. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry. 2005;18:249–255.
  • Gulick D, Gamsby JJ. Racing the clock: the role of circadian rhythmicity in addiction across the lifespan. Pharmacol Ther. 2018;188:124–139.
  • Lemoine P, Zawieja P, Ohayon MM. Associations between morningness/eveningness and psychopathology: an epidemiological survey in three in-patient psychiatric clinics. J Psychiatr Res. 2013;47:1095–1098.
  • Workshop Participants, Roth T. Does effective management of sleep disorders reduce substance dependence? Drugs. 2009;69(Suppl 2):65–75.
  • Banach E, Pawlak J, Kapelski P, et al. Clock genes polymorphisms in male bipolar patients with comorbid alcohol abuse. J Affect Disord. 2018;241:142–146.
  • Hasler BP, Smith LJ, Cousins JC, et al. Circadian rhythms, sleep, and substance abuse. Sleep Med Rev. 2012;16:67–81.
  • Geoffroy PA, Micoulaud Franchi JA, Lopez R, et al. The use of melatonin in adult psychiatric disorders: expert recommendations by the French institute of medical research on sleep (SFRMS). Encephale. 2019;45:413–423.
  • Brower KJ, Conroy DA, Kurth ME, et al. Ramelteon and improved insomnia in alcohol-dependent patients: a case series. J Clin Sleep Med. 2011;7:274–275.
  • de Bodinat C, Guardiola-Lemaitre B, Mocaër E, et al. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov. 2010;9:628–642.
  • Gahr M, Kratzer W, Fuchs M, et al. Safety and tolerability of agomelatine: focus on hepatotoxicity. Curr Drug Metab. 2014;15:694–702.
  • Grosshans M, Mutschler J, Luderer M, et al. Agomelatine is effective in reducing insomnia in abstinent alcohol-dependent patients. Clin Neuropharmacol. 2014;37:6–8.
  • Friedmann PD, Rose JS, Swift R, et al. Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial. Alcohol Clin Exp Res. 2008;32:1652–1660.
  • Karam-Hage M, Brower KJ. Open pilot study of gabapentin versus trazodone to treat insomnia in alcoholic outpatients. Psychiatry Clin Neurosci. 2003;57:542–544.
  • Le Bon O, Murphy JR, Staner L, et al. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations. J Clin Psychopharmacol. 2003;23:377–383.
  • Monnelly EP, Locastro JS, Gagnon D, et al. Quetiapine versus trazodone in reducing rehospitalization for alcohol dependence: a large data-base study. J Addict Med. 2008;2:128–134.
  • Cornelius JR, Douaihy AB, Clark DB, et al. Mirtazapine in comorbid major depression and alcohol dependence: an open-label trial. J Dual Diagn. 2012;8:200–204.
  • Cornelius JR, Douaihy AB, Clark DB. et al. Mirtazapine in comorbid major depression and alcohol use disorder: a long-term follow-up study. J Addict Behav Ther Rehabil. 2013;3.
  • Cornelius JR, Chung T, Douaihy AB, et al. Mirtazapine in comorbid major depression and an alcohol use disorder: a double-blind placebo-controlled pilot trial. Psychiatry Res. 2016;242:326–330.
  • de Bejczy A, Söderpalm B. The effects of mirtazapine versus placebo on alcohol consumption in male high consumers of alcohol: a randomized, controlled trial. J Clin Psychopharmacol. 2015;35:43–50.
  • Yoon S-J, Pae C-U, Kim D-J, et al. Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study. Prog Neuro Psychopharmacol Biol Psychiatry. 2006;30:1196–1201.
  • Brunette MF, Akerman SC, Dawson R, et al. An open-label pilot study of quetiapine plus mirtazapine for heavy drinkers with alcohol use disorder. Alcohol. 2016;53:45–50.
  • Altintoprak AE, Zorlu N, Coskunol H, et al. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study. Hum Psychopharmacol. 2008;23:313–319.
  • Agabio R, Trogu E, Pani PP. Antidepressants for the treatment of people with co-occurring depression and alcohol dependence. Cochrane Database Syst Rev. 2018;4:CD008581.
  • Ahmed S, Bachu R, Kotapati P, et al. Use of gabapentin in the treatment of substance use and psychiatric disorders: a systematic review. Front Psychiatry. 2019;10:228.
  • Ahmed S, Stanciu CN, Kotapati PV, et al. Effectiveness of gabapentin in reducing cravings and withdrawal in alcohol use disorder: a meta-analytic review. Prim Care Companion CNS Disord. 2019;21.
  • Mason BJ, Quello S, Shadan F. Gabapentin for the treatment of alcohol use disorder. Expert Opin Investig Drugs. 2018;27:113–124.
  • Brower KJ, Myra Kim H, Strobbe S, et al. A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcohol Clin Exp Res. 2008;32:1429–1438.
  • Trevisan LA, Ralevski E, Keegan K, et al. Alcohol detoxification and relapse prevention using valproic acid versus gabapentin in alcohol-dependent patients. Addict Disord Their Treat. 2008;7:119–128.
  • Anton RF, Myrick H, Wright TM, et al. Gabapentin combined with naltrexone for the treatment of alcohol dependence. Am J Psychiatry. 2011;168:709–717.
  • Anton RF, Myrick H, Baros AM, et al. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J Clin Psychopharmacol. 2009;29:334–342.
  • Mason BJ, Quello S, Goodell V, et al. Gabapentin treatment for alcohol dependence: a randomized clinical trial. JAMA Intern Med. 2014;174:70–77.
  • Falk DE, Ryan ML, Fertig JB, et al. Gabapentin enacarbil extended-release for alcohol use disorder: a randomized, double-blind, placebo-controlled, multisite trial assessing efficacy and safety. Alcohol Clin Exp Res. 2019;43:158–169.
  • Johnson BA, Rosenthal N, Capece JA, et al. Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med. 2008;168:1188–1199.
  • Carton L, Cottencin O, Lapeyre-Mestre M, et al. Off-label prescribing of antipsychotics in adults, children and elderly individuals: a systematic review of recent prescription trends. Curr Pharm Des. 2015;21:3280–3297.
  • Coe HV, Hong IS. Safety of low doses of quetiapine when used for insomnia. Ann Pharmacother. 2012;46:718–722.
  • Tassniyom K, Paholpak S, Tassniyom S, et al. Quetiapine for primary insomnia: a double blind, randomized controlled trial. J Med Assoc Thai. 2010;93:729–734.
  • Chakravorty S, Hanlon AL, Kuna ST, et al. The effects of quetiapine on sleep in recovering alcohol-dependent subjects: a pilot study. J Clin Psychopharmacol. 2014;34:350–354.
  • Litten RZ, Fertig JB, Falk DE, et al. A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients. Alcohol Clin Exp Res. 2012;36:406–416.
  • Sheehan DV, Locklear J, Svedsäter H, et al. Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarate. Int Clin Psychopharmacol. 2012;27:239–248.
  • Martinotti G, Andreoli S, Di Nicola M, et al. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics. Hum Psychopharmacol. 2008;23:417–424.
  • Perney P, Lehert P, Mason BJ. Sleep disturbance in alcoholism: proposal of a simple measurement, and results from a 24-week randomized controlled study of alcohol-dependent patients assessing acamprosate efficacy. Alcohol Alcohol. 2012;47:133–139.
  • Staner L, Boeijinga P, Danel T, et al. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects. Alcohol Clin Exp Res. 2006;30:1492–1499.
  • Perney P, Lehert P. Insomnia in alcohol-dependent patients: prevalence, risk factors and acamprosate effect: an individual patient data meta-analysis. Alcohol Alcohol. 2018;53:611–618.
  • Association AP. Diagnostic and statistical manual of mental disorders DSM-IV-TR. 4th ed. Arlington: American Psychiatric Publishing, Inc.; 2000.
  • Simou E, Britton J, Leonardi-Bee J. Alcohol and the risk of sleep apnoea: a systematic review and meta-analysis. Sleep Med. 2018;42:38–46.
  • Geoffroy PA, Micoulaud Franchi J-A, Maruani J, et al. Clinical characteristics of obstructive sleep apnea in bipolar disorders. J Affect Disord. 2018;245:1–7.
  • Koob GF, Colrain IM. Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework. Neuropsychopharmacology. 2020 Jan;45(1):141–165. doi:10.1038/s41386-019-0446-0. Epub 2019 Jun 24.
  • Auger RR, Burgess HJ, Emens JS, et al. Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An update for 2015: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med. 2015;11:1199–1236.
  • Beaulieu-Bonneau S, Ivers H, Guay B, et al. Long-term maintenance of therapeutic gains associated with cognitive-behavioral therapy for insomnia delivered alone or combined with zolpidem. Sleep. 2017 Mar 1;40(3). doi:10.1093/sleep/zsx002.
  • Kolla BP, Schneekloth T, Mansukhani MP, et al. The association between sleep disturbances and alcohol relapse: a 12-month observational cohort study. Am J Addict. 2015;24:362–367.
  • Carton L, Pignon B, Baguet A, et al. Influence of comorbid alcohol use disorders on the clinical patterns of major depressive disorder: a general population-based study. Drug Alcohol Depend. 2018;187:40–47.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.